|
Q1 FY2027
As of Sep 30, 2026
|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||
| Total Current Assets | ||||||||
| Total Intangible Assets, Net | ||||||||
| Total Assets | ||||||||
| Accounts payable-related party | ||||||||
| Deferred revenue | ||||||||
| Related party loan | ||||||||
| Total Current Liabilities | ||||||||
| Total Liabilities | ||||||||
| Common stock, par value $0.0001; 75,000,000 shares authorized, 5,735,200 and 5,735,200 shares issued and outstanding as of September 30, 2026 and June 30, 2026, respectively | ||||||||
| Additional paid in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Stockholders’ Deficit | ||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
